Trials / Unknown
UnknownNCT03193008
Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,400 (estimated)
- Sponsor
- Corporacion Parc Tauli · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
AUS/FNAC allows the identification of tumors without axillary tumor involvement, or with low axillary tumor burden, many of which do not benefit from SLNB, in the staging of early breast cancer. Objective: To calculate the negative predictive value of AUS/FNAC in those patients with breast cancer who meet ACOSOG Z0011 criteria.
Conditions
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2017-07-15
- Completion
- 2017-07-15
- First posted
- 2017-06-20
- Last updated
- 2017-06-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03193008. Inclusion in this directory is not an endorsement.